Association of cytoreductive nephrectomy and survival in the immune checkpoint inhibitor era.

Joseph A. Miccio,Sung Jun Ma,Oluwadamilola T. Oladeru,Daniel X. Yang,Gabrielle W. Peters,Krishan Jethwa,Henry S. Park,Michael E. Hurwitz,Michael Leapman,Preston Sprenkle,Paul Nguyen,James B. Yu,Kimberly L. Johung

Association of cytoreductive nephrectomy and survival in the immune checkpoint inhibitor era.

2020

Joseph A. Miccio
Sung Jun Ma
Oluwadamilola T. Oladeru
Daniel X. Yang
Gabrielle W. Peters
Krishan Jethwa
Henry S. Park
Michael E. Hurwitz
Michael Leapman
Preston Sprenkle
Paul Nguyen
James B. Yu
Kimberly L. Johung

748Background: Cytoreductive nephrectomy (CN) for patients (pts) with metastatic renal cell carcinoma (mRCC) improved overall survival (OS) in the interferon (IFN) era, but the benefit of CN in the...

Keywords:

Nephrectomy
Oncology
Pathology
Immune checkpoint
Internal medicine
Medicine
Renal cell carcinoma
Interferon
immune checkpoint inhibitors
overall survival
cytoreductive nephrectomy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations